Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) — Net Asset Momentum
Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) recorded a net asset momentum of -6.0% as of December 2025, with net assets of CN¥1.72 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Shanghai Haishun New Pharmaceutical Pack (300501) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Net Asset Momentum (2011–2025)
This chart tracks Shanghai Haishun New Pharmaceutical Packaging Co Ltd's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is -6.0%, with net assets of CN¥1.72 Billion CNY as of December 2025. Read 300501 total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2025)
The table below shows the complete annual net asset history for Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Shanghai Haishun New Pharmaceutical Pack (300501) market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.72 Billion | CN¥2.91 Billion | CN¥1.19 Billion | ▼ -6.0% |
| 2024 | CN¥1.83 Billion | CN¥2.89 Billion | CN¥1.06 Billion | ▼ -4.9% |
| 2023 | CN¥1.92 Billion | CN¥2.99 Billion | CN¥1.06 Billion | ▲ +14.5% |
| 2022 | CN¥1.68 Billion | CN¥2.31 Billion | CN¥625.80 Million | ▲ +5.9% |
| 2021 | CN¥1.59 Billion | CN¥2.26 Billion | CN¥678.55 Million | ▲ +80.9% |
| 2020 | CN¥876.40 Million | CN¥1.41 Billion | CN¥529.08 Million | ▲ +15.0% |
| 2019 | CN¥762.37 Million | CN¥1.23 Billion | CN¥472.49 Million | ▲ +6.6% |
| 2018 | CN¥714.84 Million | CN¥942.48 Million | CN¥227.64 Million | ▲ +12.8% |
| 2017 | CN¥633.69 Million | CN¥709.87 Million | CN¥76.19 Million | ▲ +6.6% |
| 2016 | CN¥594.42 Million | CN¥683.89 Million | CN¥89.47 Million | ▲ +119.4% |
| 2015 | CN¥270.92 Million | CN¥338.83 Million | CN¥67.91 Million | ▲ +16.7% |
| 2014 | CN¥232.14 Million | CN¥288.04 Million | CN¥55.90 Million | ▲ +18.5% |
| 2013 | CN¥195.85 Million | CN¥257.08 Million | CN¥61.23 Million | ▲ +18.8% |
| 2012 | CN¥164.87 Million | CN¥220.32 Million | CN¥55.46 Million | ▲ +26.0% |
| 2011 | CN¥130.81 Million | CN¥187.19 Million | CN¥56.39 Million | — |